Rigel Pharmaceuticals

Rigel’s Rezlidhia (olutasidenib) Gets FDA Approval for Relapsed or Refractory AML
Rigel’s Rezlidhia (olutasidenib) Gets FDA Approval for Relapsed or Refractory AML
Xtalks
Rigel Pharmaceuticals
Rezlidhia
olutasidenib
FDA
AML
Flag link:
Rigel bets $230M that Forma's leukemia drug gets in formation with FDA
Rigel bets $230M that Forma's leukemia drug gets in formation with FDA
Fierce Biotech
Rigel Pharmaceuticals
Forma Therapeutics
olutasidenib
leukemia
FDA
Flag link:
End-of-Year Restructuring Means Layoffs for These Companies
End-of-Year Restructuring Means Layoffs for These Companies
BioSpace
restructuring
Rigel Pharmaceuticals
Zymergen
Esperion Therapeutics
Amarin
Theravance
Sanofi
Acorda Therapeutics
CureVac
Ziopharm Oncology
Flag link:
Why Did the FDA Reject Rigel's EUA Application for Its COVID-19 Therapy?
Why Did the FDA Reject Rigel's EUA Application for Its COVID-19 Therapy?
Motley Fool
Rigel Pharmaceuticals
Emergency Use Authorization
FDA
Tavalisse
COVID-19
Flag link:
FDA denies Rigel's COVID-19 hopeful Tavalisse for hospitalized patients, asks for late-stage data
FDA denies Rigel's COVID-19 hopeful Tavalisse for hospitalized patients, asks for late-stage data
Fierce Pharma
Rigel Pharmaceuticals
Tavalisse
COVID-19
FDA
Flag link:
Catalyst, Zogenix, Rigel and Pfizer kick off pharma's July price hikes: report
Catalyst, Zogenix, Rigel and Pfizer kick off pharma's July price hikes: report
Fierce Pharma
drug pricing
Pfizer
Zogenix
Rigel Pharmaceuticals
Catalyst Pharmaceuticals
Flag link:
Lilly wagers almost $1B on Rigel's drugs for immune and nervous systems
Lilly wagers almost $1B on Rigel's drugs for immune and nervous systems
BioPharma Dive
Eli Lilly
Rigel Pharmaceuticals
autoimmune disease
inflammatory disease
Flag link:
Rigel enrolls first patients in phase 2 Covid-19 trial of fostamatinib
Rigel enrolls first patients in phase 2 Covid-19 trial of fostamatinib
Pharmaceutical Business Review
Rigel Pharmaceuticals
clinical trials
fostamatinib
COVID-19
Flag link:
Why Rigel Pharmaceuticals Stock Skyrocketed 91% Today
Why Rigel Pharmaceuticals Stock Skyrocketed 91% Today
Motley Fool
COVID-19 pneumonia
Rigel Pharmaceuticals
clinical trials
fostamatinib
Flag link:
2 Biotechs Battling Immune Diseases
2 Biotechs Battling Immune Diseases
Motley Fool
Rigel Pharmaceuticals
Momenta Pharmaceuticals
autoimmune disease
biologics
small molecule drugs
Flag link:
Rigel Announces Pricing Of Common Stock Offering
Rigel Announces Pricing Of Common Stock Offering
CP Wire
Rigel Pharmaceuticals
stock offering
Flag link:
Rigel Announces Pricing Of Common Stock Offering
Rigel Pharmaceuticals
Flag link:
Rigel Proposes Stock Offering on Heels of Tavalisse Approval
Rigel Proposes Stock Offering on Heels of Tavalisse Approval
CP Wire
Rigel Pharmaceuticals
stock offering
Tavalisse
Flag link:
Rigel Proposes Stock Offering on Heels of Tavalisse Approval
Rigel Pharmaceuticals
Flag link:
FDA Approves First in Class TAVALISSE for Chronic Immune Thrombocytopenia (ITP) in Adults
FDA Approves First in Class TAVALISSE for Chronic Immune Thrombocytopenia (ITP) in Adults
CP Wire
Rigel Pharmaceuticals
Tavalisse
chronic immune thrombocytopenia
FDA
Flag link:
FDA Approves First in Class TAVALISSE for Chronic Immune Thrombocytopenia (ITP) in Adults
Rigel Pharmaceuticals
Tavalisse
chronic immune thrombocytopenia
Flag link:
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
TheStreet.com
FDA
drug approvals
Alkermes
ALKS-5461
CytRx
aldoxorubicin
Dynavax Technologies
HEPLISAV-B
Intra-Cellular Therapies
ITI-007
Novan
SB204
Portola Pharmaceuticals
betrixaban
PTC Therapeutics
ataluren
Rigel Pharmaceuticals
fostamatinib
TG Therapeutics
ublituximab
Flag link:
Rigel Pharma CEO pulls back the curtain on drug deal with Bristol-Myers
Rigel Pharma CEO pulls back the curtain on drug deal with Bristol-Myers
Bizjournals.com
Rigel Pharmaceuticals
Bristol-Myers Squibb
Flag link:
Rigel experimental eye drug fails mid-stage study
Rigel experimental eye drug fails mid-stage study
Yahoo/Reuters
Rigel Pharmaceuticals
R348
dry eye disease
Flag link:
Rigel Pharmaceuticals initiates Phase 3 studies of fostamatinib in ITP
Rigel Pharmaceuticals initiates Phase 3 studies of fostamatinib in ITP
Yahoo/Fly on the Wall
fostamatinib
Rigel Pharmaceuticals
ITP
Flag link:

Pages